USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TARGESON, INC.
Address:
850 CARLINS WAY
CHARLOTTESVILLE, VA 22903-7666
Phone:
N/A
URL:
N/A
EIN:
132027135
DUNS:
963312215
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $259,721.00 1
SBIR Phase II $1,338,742.00 1

Award List:

Ultrasound-based molecular imaging probe for imaging acute myocardial syndromes

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$259,721.00
Agency:
HHS
Principal Investigator:
Joshua J. Rychak – 877-290-4043
Abstract:
DESCRIPTION (provided by applicant): Acute coronary syndromes (ACS) account for an increasing level of healthcare expense although patient morbidity and mortality remain relatively high. Current methods for assessing the extent of cardiac ischemic injury in an acute setting offer limited sensitivity… More

Ultrasound-triggered delivery of siRNA as treatment for diabetic kidney disease

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,338,742.00
Agency:
HHS
Principal Investigator:
Joshua J. Rychak – 877-290-4043
Abstract:
DESCRIPTION (provided by applicant): Gene therapy in the context of diabetic kidney disease holds tremendous promise, although concrete progress in the field has been difficult to achieve. Specifically, the growth factor TGF-2 is known to play a critical role in glomerular matrix expansion and… More